Literature DB >> 21889116

Neuropsychiatric symptoms in Alzheimer's disease.

Constantine G Lyketsos1, Maria C Carrillo, J Michael Ryan, Ara S Khachaturian, Paula Trzepacz, Joan Amatniek, Jesse Cedarbaum, Robert Brashear, David S Miller.   

Abstract

Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and in prodromal phases, such as mild cognitive impairment. Despite decades of research, reliable treatments for dementia-associated NPS have not been found, and those that are in widespread use present notable risks for people using these medications. An Alzheimer's Association Research Roundtable was convened in the spring of 2010 to review what is known about NPS in Alzheimer's disease, to discuss classification and underlying neuropathogenesis and vulnerabilities, and to formulate recommendations for new approaches to tailored therapeutics.
Copyright © 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21889116      PMCID: PMC3299979          DOI: 10.1016/j.jalz.2011.05.2410

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  87 in total

1.  Apathy and cortical atrophy in Alzheimer's disease.

Authors:  C Tunnard; D Whitehead; C Hurt; L O Wahlund; P Mecocci; M Tsolaki; B Vellas; C Spenger; I Kłoszewska; H Soininen; S Lovestone; A Simmons
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-27       Impact factor: 3.485

2.  MCI patients' EEGs show group differences between those who progress and those who do not progress to AD.

Authors:  D V Moretti; G B Frisoni; C Fracassi; M Pievani; C Geroldi; G Binetti; P M Rossini; O Zanetti
Journal:  Neurobiol Aging       Date:  2011-04       Impact factor: 4.673

3.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

4.  Hippocampal volume and incident dementia in geriatric depression.

Authors:  David C Steffens; Martha E Payne; Daniel L Greenberg; Christopher E Byrum; Kathleen A Welsh-Bohmer; H Ryan Wagner; James R MacFall
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

Review 5.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

Review 6.  Non-pharmacologic management of sleep disturbance in Alzheimer's disease.

Authors:  R David; J Zeitzer; L Friedman; A Noda; R O'Hara; P Robert; J A Yesavage
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

7.  Structural correlates of apathy in Alzheimer's disease.

Authors:  Liana G Apostolova; Gohar G Akopyan; Negar Partiali; Calen A Steiner; Rebecca A Dutton; Kiralee M Hayashi; Ivo D Dinov; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Dement Geriatr Cogn Disord       Date:  2007-06-14       Impact factor: 2.959

8.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

9.  Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.

Authors:  Krista L Lanctôt; Nathan Herrmann; Sandra E Black; Michelle Ryan; Lana S Rothenburg; Barbara A Liu; Usoa E Busto
Journal:  Am J Geriatr Psychiatry       Date:  2008-07       Impact factor: 4.105

10.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

View more
  208 in total

1.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Translation of the Care of Persons with Dementia in their Environments (COPE) intervention in a publicly-funded home care context: Rationale and research design.

Authors:  Richard H Fortinsky; Laura N Gitlin; Laura T Pizzi; Catherine Verrier Piersol; James Grady; Julie T Robison; Sheila Molony
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

3.  Overcoming a Bad Day: a Qualitative Look into the Dementia Caregiving Experiences of Mexican-Origin Women in East Los Angeles.

Authors:  Lourdes R Guerrero; Carolyn A Mendez-Luck
Journal:  J Cross Cult Gerontol       Date:  2019-12

4.  Self-reported personality traits are prospectively associated with proxy-reported behavioral and psychological symptoms of dementia at the end of life.

Authors:  Angelina R Sutin; Yannick Stephan; Martina Luchetti; Antonio Terracciano
Journal:  Int J Geriatr Psychiatry       Date:  2017-09-04       Impact factor: 3.485

5.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

7.  Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.

Authors:  Donovan T Maust; H Myra Kim; Claire Chiang; Helen C Kales
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

8.  Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms.

Authors:  Ryan M Silwanowicz; Donovan T Maust; Lisa S Seyfried; Claire Chiang; Claire Stano; Helen C Kales
Journal:  Int J Geriatr Psychiatry       Date:  2016-10-04       Impact factor: 3.485

9.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

10.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.